Tuesday, 27 October 2020

Oxford vaccine immune response triggers hopes

Coronavirus vaccine being developed by AstraZeneca and Oxford University has successfully triggered a strong immune response among both young and old. The announcement by AstraZeneca has triggered hopes across countries ravaged by the Covid-19 pandemic. Meanwhile in India, Bharat Biotech and ICMR will be entering Phase III clinical trials of the indigenous vaccine, Covaxin.


No comments:

Featured Post

Hindenburg Crashes without any cogent reason

TODAY'S ECONOMICS once again proved correct  Esteemed readers will recollect that earlier TODAY'S ECONOMICS had in its editorial (D...